Search
A team of experts at Memorial Sloan Kettering shared their insights on colorectal cancer and general digestive health in an Information Session for patients, caregivers and those at increased risk for the disease.
The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene.
Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.
Learn about Verdun Perry’s devotion to fund rare cancer research at MSK.
New findings provide details about the hidden organization of the cytoplasm, showing it makes a big difference where in that cellular broth that messenger RNA (mRNA) get translated into proteins. The findings hold promise for increasing or altering the production of proteins in mRNA vaccines and therapies.
A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Meet Roseann Tucci and her daughter Gabriella, both nurses dedicated to caring for patients in the Department of Pediatrics at Memorial Sloan Kettering.
New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes; investigates opportunities for restoring sensitivity to endocrine therapy; and finds acupuncture may help prostate cancer survivors wake up less often at night to urinate.
Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.